Jiatian Lin Selected Research

Drug Therapy (Chemotherapy)

1/2022	NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
1/2021	LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
11/2014	Surgical resection followed by chemotherapy may be an effective treatment strategy for primary gastrointestinal natural killer/T-cell lymphoma: a single center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiatian Lin Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2019
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2019
1	Carcinoma (Carcinomatosis) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2019
1	Inflammation (Inflammations) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Lymphoma (Lymphomas) 11/2014

Drug/Important Bio-Agent (IBA)

2	thrombospondin 3IBA 09/2023 - 01/2022
2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2019
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 08/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Orphan Nuclear ReceptorsIBA 01/2019
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2019
1	Angiopoietin-Like Protein 2IBA 01/2019

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
2	Radiotherapy 01/2022 - 01/2021